Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
about
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosisSurvival of women with inflammatory breast cancer: a large population-based studyEpidemiological risk factors associated with inflammatory breast cancer subtypes.Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.Effect of early palliative care on quality of life in patients with non-small-cell lung cancer.Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
P2860
Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Outcomes After Multidisciplina ...... djuvant HER2-directed Therapy.
@en
Outcomes After Multidisciplina ...... djuvant HER2-directed Therapy.
@nl
type
label
Outcomes After Multidisciplina ...... djuvant HER2-directed Therapy.
@en
Outcomes After Multidisciplina ...... djuvant HER2-directed Therapy.
@nl
prefLabel
Outcomes After Multidisciplina ...... djuvant HER2-directed Therapy.
@en
Outcomes After Multidisciplina ...... djuvant HER2-directed Therapy.
@nl
P2093
P2860
P1476
Outcomes After Multidisciplina ...... djuvant HER2-directed Therapy.
@en
P2093
Ana M Gonzalez-Angulo
Anthony Lucci
Chiaojung Jillian Tsai
Massimo Cristofanilli
Naoto T Ueno
Pamela K Allen
Savitri Krishnamurthy
Thomas A Buchholz
Vicente Valero
P2860
P304
P356
10.1097/COC.0B013E3182937921
P577
2015-06-01T00:00:00Z